Status:

COMPLETED

Effects of Nebivolol on Subclinical Left Ventricular dySfunction: A Comparative Study Against Metoprolol

Lead Sponsor:

Berlin-Chemie Menarini

Conditions:

Primary Arterial Hypertension

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Summary: * Study title: Effects of Nebivolol on subclinical left ventricular dysfunction. A comparative study against Metoprolol. (ENESYS study) * Study phase: 3 * Study design (parallel, cross-over,...

Detailed Description

STUDY OBJECTIVES 1. PRIMARY: * Longitudinal myocardial velocities at rest (assessed by tissue Doppler echocardiography) * Systolic functional reserve (calculated as the absolute and relative i...

Eligibility Criteria

Inclusion

  • aged 18 years or older, men and women, hospitalized and outpatients
  • with a history of primary arterial hypertension
  • with a daytime ambulatory blood pressure \>140 and/or \>90 mm Hg
  • with left ventricular hypertrophy: LVMI \> 125 g/m2 for men, and \> 110 g/m2 for women, by Devereux formula, as recommended by the ESH-ESC guidelines (14)
  • in sinus rhythm
  • consented, by signing the Informed Consent

Exclusion

  • Severe arterial hypertension (systolic blood pressure \> 180 mm Hg and/or diastolic blood pressure \> 110 mm Hg)
  • Any history of coronary heart disease (stable angina, acute coronary syndromes, myocardial infarction)
  • Any history of cerebrovascular disease
  • Renal impairment (creatinine \> 1.5 mg% for men, \> 1.4 mg% for women)
  • Left ventricular global systolic dysfunction (EF \< 45%)
  • More than mild valvar (mitral or aortic) regurgitation
  • Hypertrophic cardiomyopathy
  • Pericarditis
  • Cor pulmonale
  • Pregnancy or lactating women
  • Any significant co-morbidities
  • Contraindication to beta-blocker therapy
  • Concomitant treatment with other beta-blockers
  • Participation to another investigational study in the last 3 months

Key Trial Info

Start Date :

April 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2009

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00942487

Start Date

April 1 2005

End Date

July 1 2009

Last Update

July 21 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University and Emergency Hospital

Bucharest, Romania, 050098